Resources - CDC Yellow Book 2024
CDC-INFO NATIONAL CONTACT CENTER
For clinicians & the public (English & Spanish)
M–F, 8am–8pm Eastern
800-CDC-INFO (800-232-4636)
www.cdc.gov/info
CDC EMERGENCY OPERATIONS CENTER
Emergency/urgent patient care assistance
24 hours a day, 7 days a week
770-488-7100
CDC DRUG SERVICE
Special biologic agents & drugs
M–F, 8am–4:30pm Eastern: 404-639-3670
After hours/weekends/holidays (emergency consultation): 770-488-7100 [email protected]
www.cdc.gov/laboratory/drugservice/formulary.html
Anthrax Vaccine Adsorbed
Anthrax immunization
Botulism Antitoxin Heptavalent (Equine), Types A-G
Botulism treatment
Diethylcarbamazine (DEC)
Lymphatic filariasis, tropical pulmonary eosinophilia, loiasis treatment
Diphtheria Antitoxin (equine)
Diphtheria treatment
Eflornithine
2nd stage African trypanosomiasis treatment (T. brucei gambiense)
Melarsoprol
2nd stage African trypanosomiasis treatment
Suramin
1st stage African trypanosomiasis treatment (T. brucei rhodesiense)
Vaccinia Vaccine
Smallpox immunization
CHIKUNGUNYA
JAPANESE ENCEPHALITIS
TICK-BORNE ENCEPHALITIS
YELLOW FEVER
Diagnostic testing
Questions about yellow fever vaccine antibody response
M–F, 8am–4:30pm Mountain: 970-221-6400
After hours/weekends/holidays (emergency consultation with on-call CDC clinician): 770-488-7100
DENGUE
Diagnostic testing & clinical management
M–F, 8am–5pm Atlantic: 787-706-2399
After hours/weekends/holidays (emergency consultation with on-call CDC clinician): 770-488-7100
www.cdc.gov/Dengue/clinicalLab/index.html
MALARIA HOTLINE
Diagnostic testing & clinical management
M–F, 9am–5pm Eastern: 855-856-4713 (toll free); or 770-488-7788
After hours/weekends/holidays (emergency consultation with on-call CDC clinician): 770-488-7100
PARASITIC DISEASES (NON-MALARIA)
Diagnostic testing & clinical management
M–F, 8am–4m Eastern: 404-718-4745
After hours/weekends/holidays (emergency consultation with on-call CDC clinician): 770-488-7100
[email protected]
Laboratorians, pathologists & other health professionals
DPDx: www.cdc.gov/dpdx/contact.html
RICKETTSIAL DISEASES
Diagnostic testing & clinical management
M–F, 8am–4:30pm Eastern: 404-639-1075
After hours/weekends/holidays (emergency consultation with on-call CDC clinician): 770-488-7100
VIRAL HEMORRHAGIC FEVERS
Diagnosis & clinical management
Ribavirin requests
Suspect case reporting
Requests for evacuation to the United States
M–F, 8:30am–5:30pm Eastern: 404-639-1115
After hours/weekends/holidays (emergency consultation with on-call CDC clinician): 770-488-7100
Dengue
To learn more about destination-specific dengue risk, please visit the following maps:
Destinations
- Brazil
- Burma (Myanmar)
- Cambodia
- China
- Dominican Republic
- Egypt
- Guatemala & Belize
- Haiti
- Jamaica
- Mexico
- Nepal
- Peru
- South Africa
- Tanzania & Zanzibar
- Thailand
- Vietnam
Hepatitis
- Age of Midpoint Population Immunity to Hepatitis A, by Country
- Worldwide Prevalence of Hepatitis B Virus Infection
- Worldwide Prevalence of Hepatitis C Virus
Influenza
Malaria
To learn more about malaria-endemic destinations, please see the following maps:
- Africa, Europe, and the Middle East
- Americas and the Caribbean
- Asia and Oceania
- Malaria Map from CDC Yellow Book, 1974
To learn more about malaria prevention recommendations, please visit the following maps:
Meningococcal Disease
Reasons for Travel
- African game parks & reserves (North)
- African game parks & reserves (South)
- Hajj/Umrah Pilgrimage
- Iguaçu Falls
Seafood Poisonings
Tuberculosis
Yellow Fever
To learn more about destination-specific yellow fever vaccine recommendations, please visit the following maps:
To learn more about yellow fever endemic zones, please see the following maps:
Dengue
Encephalitis
- Risk Areas & Transmission Season for Japanese Encephalitis
- Administration of IXIARO Japanese Encephalitis Vaccine
- Tick-borne Encephalitis Vaccine Administration Schedule
Escherichia coli
Hepatitis
Infections by Incubation Period
- Infections (Incubation less than 14 days)
- Infections (Incubation 14 days to 6 weeks)
- Infections (Incubation more than 6 weeks)
Influenza
Malaria
- Drug Interactions with Selected Antimalarials
- Reliable Supply Regimens for Malaria Treatment
- Prescribing Considerations for Malaria Chemoprophylaxis
- Dosing Information for Malaria Chemoprophylaxis
- Half-lives of Malaria Chemoprophylaxis Medications
- Changing Malaria Chemoprophylaxis Medications due to Side Effects
- Recommendations for Blood Donation Deferrals for People Returning from Malaria-Endemic Areas
Meningococcal Disease
Rabies
- Criteria for preexposure immunization for rabies
- Preexposure Immunization for Rabies
- Postexposure Immunization for Rabies
Rickettsial Diseases
Sexually Transmitted Infections (STI)
Smallpox, Cowpox, Vaccinia, and Monkeypox
Tuberculosis
Yellow Fever
- Yellow Fever Vaccine Recommendation Categories
- Yellow Fever Vaccine
- Countries Requiring Proof of Yellow Fever Vaccination
- Countries with Risk for Yellow Fever Virus Transmission
- Countries with Low Potential for Exposure to Yellow Fever Virus
Zoonotic Diseases and Pathogens
Air Quality
Federal Quarantine Orders
Immigrants, Refugees and Other Migrants
- Arrivals to the United States, 2019
- Health Examination and Intervention Requirements
- New Arrival Infectious Disease Screening Recommendations
- New Arrival Toxic and Metabolic Screening Recommendations
- Infectious Disease Screening Recommendations for International Adoptees
Mass Gatherings
Resources for Travelers
- LGBTQ+ Travelers
- Telemedicine
- Travelers with Disabilities or Chronic Illnesses
- Accommodations & Human Rights Frameworks for People with Disabilities
- Travelers with Chronic Illnesses
- Travelers Purchasing Medicines and Medical Products Overseas
- Medical Tourism Resources
- Study Abroad Students, Health Centers, and Programs
- International Business Travelers
- Tick Removal Instructions
- Adverse Clinical Effects of Alcohol Consumption
- Risk Factors for Road Traffic Crashes and Injuries
Travel Health Statistics and Trends
- Motor Vehicle Crash Trends
- Injury and Death Leading Causes
- CDC Yellow Book Map Trends
- Humanitarian Assistance Trends
Water Safety and Disinfection
International Certificate of Vaccination or Prophylaxis (ICVP)
- Instructions on How to Fill Out the ICVP
- Medical Contraindication to Vaccination Section of ICVP Instructions
Medicines and Treatments
- Antibiotics for Acute Diarrhea
- Drug Interactions with Antibiotics
- Drug Interactions with Acetazolamide
- Altitude Illness Medications
- Importation of Medications
- Tetanus Prophylaxis
Travel Vaccinations and Immunizations
- Pre-Travel Consultation Vaccines
- Recommended and minimum ages, minimum intervals for vaccine doses
- Immunization of Immunocompromised Adults: Live Vaccines
- Immunization of Immunocompromised Adults: Non-Live Vaccines
- Biologic Medications that Preclude Use of Live Vaccines
- Health Conditions and Treatments Not Needing Immunization Precautions
- Vaccine Preventable Diseases: Bacterial
- Vaccine Preventable Diseases: Viral
- Typhoid Fever Vaccines
- Alternative Adult Polio Vaccine Dosing Schedules
Pre-Travel Consultations
- Medical History and Travel Risk Assessment
- Key Discussion Topics
- Special Considerations for Travelers with Chronic Illnesses
- Acute Mountain Sickness Risk Categories
- Ascent Risk to High Elevations
Post-Travel Evaluations
- Complete Travel History for Ill Returned Travelers
- Causes of Fever in the Tropics, by Geographical Area
- Causes of Skin Lesions in Returned Travelers
- Asymptomatic Traveler Screening Considerations
- Rapid Diagnostic Tests
- Lateral-flow Immunochromatographic Tests
- Multiplex Molecular Panels
- Fever-associated Infectious Diseases
- Febrile Syndromes with Public Health Concern